Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice

Experimental and Molecular Medicine

Volumn 49, Issue 8, 2017, Pages

  Hu, Jingjuan ^a   Luo, Haihua ^a   Wang, Jieyan ^a   Tang, Wenli ^a   Lu, Junqi ^a   Wu, Shan ^a   Xiong, Zhi ^a   Yang, Guizhi ^b   Chen, Zhenguo ^a   Lan, Tian ^b   Zhou, Hongwei ^a   Nie, Jing ^a   Jiang, Yong ^a   Chen, Peng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CHRONIC HIGH SALT DIET; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSBIOSIS; ENTERIC DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; GENE EXPRESSION PROFILING; INTESTINE MUCOSA PERMEABILITY; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; ACUTE KIDNEY FAILURE; ANIMAL; BACTEROIDETES; BLOOD PRESSURE; C57BL MOUSE; DRUG EFFECT; FECES; FIRMICUTES; GASTROINTESTINAL TRACT; GENETICS; INTESTINE FLORA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERMEABILITY; TIME FACTOR;

RNA;

ACUTE KIDNEY INJURY; ANIMALS; BACTEROIDETES; BLOOD PRESSURE; DYSBIOSIS; FECES; FIRMICUTES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; MALE; MICE; MICE, INBRED C57BL; PERMEABILITY; RNA; SODIUM CHLORIDE, DIETARY; TIME FACTORS;

EID: 85047786169     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2017.122     Document Type: Article

References (41)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.
2. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013; 61: 457–464.
3. Ruilope LM, Bakris GL. Renal function and target organ damage in hypertension. Eur Heart J 2011; 32: 1599–1604.
4. Dahl LK, Leitl G, Heine M. Influence of dietary potassium and sodium/ potassium molar ratios on the development of salt hypertension. J Exp Med 1972; 136: 318–330.
5. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003; 41: 592–597.
6. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98: 2621–2628.
7. Antonios TF, MacGregor GA. Salt–more adverse effects. Lancet 1996; 348: 250–251.
8. Chen P, Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut Liver 2014; 8: 237–241.
9. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146: 1513–1524.
10. Schnabl B. Linking intestinal homeostasis and liver disease. Curr Opin Gastroenterol 2013; 29: 264–270.
11. Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 2015; 148: 203–214.
12. Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, Llorente C et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 2016; 19: 227–239.
13. Yin J, Prabhakar M, Wang S, Liao SX, Peng X, He Y et al. Different dynamic patterns of β-lactams, quinolones, glycopeptides and macrolides on mouse gut microbial diversity. PLoS ONE 2015; 10: e0126712.
14. Chen P, Han Z, Yang P, Zhu L, Hua Z, Zhang J. Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride. Hepatol Res 2010; 40: 1117–1127.
15. Li Q, Cao C, Zhang C, Zheng S, Wang Z, Wang L et al. The identification of Cucumis sativus Glabrous 1 (CsGL1) required for the formation of trichomes uncovers a novel function for the homeodomain-leucine zipper I gene. J Exp Bot 2015; 66: 2515–2526.
16. Yu Y, Zeng L, Yan Z, Liu T, Sun K, Zhu T et al. Identification of Ramie genes in response to Pratylenchus coffeae infection challenge by digital gene expression analysis. Int J Mol Sci 2015; 16: 21989–22007.
17. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5: 621–628.
18. Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2015; 290: 5647–5660.
19. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 2008; 3: e2836.
20. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313: 1126–1130.
21. Yu LC, Shih YA, Wu LL, Lin YD, Kuo WT, Peng WH et al. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis. Am J Physiol Gastrointest Liver Physiol 2014; 307: G824–G835.
22. Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011; 53: 96–105.
23. Su L, Nalle SC, Shen L, Turner ES, Singh G, Breskin LA et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013; 145: 407–415.
24. LaTuga MS, Ellis JC, Cotton CM, Goldberg RN, Wynn JL, Jackson RB et al. Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants. PLoS ONE 2011; 6: e27858.
25. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108: 218–224.
26. Ghosh SS, Bie J, Wang J, Ghosh S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR−/− mice–role of intestinal permeability and macrophage activation. PLoS ONE 2014; 9: e108577.
27. Muskiet MH, Smits MM, Morsink LM, Diamant M. The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? Nat Rev Nephrol 2014; 10: 88–103.
28. Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 2011; 26: 938–947.
29. Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 2013; 21: E607–E615.
30. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480–484.
31. Chen P, Stärkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 2015; 61: 883–894.
32. Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 2011; 8: 152–168.
33. Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000; 47: 79–87.
34. Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013; 62: 531–539.
35. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451–1463.
36. Yuhan R, Koutsouris A, Savkovic SD, Hecht G. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology 1997; 113: 1873–1882.
37. Mangell P, Nejdfors P, Wang M, Ahrné S, Weström B, Thorlacius H et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 2002; 47: 511–516.
38. Wu LL, Peng WH, Kuo WT, Huang CY, Ni YH, Lu KS et al. Commensal bacterial endocytosis in epithelial cells is dependent on myosin light chain kinase-activated brush border fanning by interferon-γ. Am J Pathol 2014; 184: 2260–2274.
39. Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE et al. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007; 137: 1901–1907.
40. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005; 288: G422–G430.
41. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464–474.